Corvamine

Corvamin: a peripheral vasodilator for the treatment of cardiovascular diseases

Corvamin, also known by its international name Molsidomine, is a peripheral vasodilator used to treat various cardiovascular diseases. The drug is produced by the French pharmaceutical company Natur Product and is presented in the form of tablets for oral administration.

Corvamin is widely used in clinical practice for the treatment of coronary heart disease. It is effectively used for the prevention and relief of angina attacks, especially in patients who cannot tolerate or do not achieve the desired effect from the use of nitrates. In addition, the drug can be used after hemodynamic stabilization for the treatment of acute myocardial infarction.

Corvamin can also be used for pulmonary hypertension, chronic cor pulmonale and chronic congestive heart failure as part of combination therapy.

However, before using Corvamin, contraindications must be taken into account. The drug is not recommended for hypersensitivity to its components, severe hypotension, cardiogenic shock, or decreased central venous pressure. It is also not recommended to use the drug in the first trimester of pregnancy, and breastfeeding should be stopped during treatment.

Like any medicine, Corvamin may cause side effects. Some of these include headache, dizziness, low blood pressure, collapse, glaucoma, facial flushing and allergic reactions including skin manifestations and bronchospasm.

The interaction of Corvamin with other drugs should also be taken into account. Vasodilators may enhance the hypotensive effect of the drug, and alcohol consumption may increase its effect.

Information on overdose of Corvamin is limited, therefore, if an overdose is suspected, medical attention should be sought.

When using Corvamin, special instructions should be followed. When first prescribing the drug, blood pressure control is necessary, as intense headaches and excessive hypotension with loss of consciousness are possible. In patients with hepatic or severe renal failure, as well as in the elderly, the drug is prescribed with caution, starting with low doses. Alcohol consumption should be avoided during treatmentPlease note that the information provided above is based on the knowledge available up until September 2021, and there may be updates or new developments regarding Corvamin since then. It is always best to consult a healthcare professional or refer to the latest medical guidelines for the most accurate and up-to-date information.